Sign in

CIK 0001527753

  • Non-accelerated filer
  • Smaller reporting company

Personalis, Inc.

Sign in to watch
Ticker
PSNL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275411038
Phone
+1 650-752-1300
Business address
6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
  1. 4 Open-market sale Chief Scientific Officer sold 1,101 shares at $22.75 ($25,048)
  2. 4 Grant or award President and CEO acquired 75,000 shares (grant or award)
  3. 4 Open-market sale President and CEO sold 110,000 shares at an average $22.43 ($2,467,273)
  4. 4 Open-market sale Chief Financial Officer sold 2,899 shares at $21.57 ($62,531)
  5. 4 Open-market sale Chief Scientific Officer sold 291 shares at $21.57 ($6,277)
  6. 4 Grant or award Director acquired 2,736 shares (grant or award)
  7. 4 Grant or award Director acquired 2,736 shares (grant or award)
  8. 4 Grant or award Director acquired 2,736 shares (grant or award)
  9. 4 Grant or award Director acquired 2,736 shares (grant or award)
  10. 4 Grant or award Director acquired 2,736 shares (grant or award)
  11. 4 Grant or award Director acquired 2,736 shares (grant or award)
  12. 4 Grant or award Chief Scientific Officer acquired 20,000 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
  14. 4 Grant or award President and CEO acquired 53,750 shares (grant or award)
  15. 4 Open-market sale Chief Scientific Officer sold 40,000 shares at an average $25.69 ($1,027,592)
  16. 4 Open-market sale Chief Scientific Officer sold 1,130 shares at $26.73 ($30,205)
  17. 4 Open-market sale Chief Financial Officer sold 2,446 shares at $26.73 ($65,382)
  18. 4 Grant or award Director acquired 2,610 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale Chief Financial Officer sold 3,022 shares at $32.60 ($98,517)

Page 11 of 15 · 289 filings